BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29028092)

  • 21. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
    Zhang Y; Li H; Han J; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer.
    Han W; Du X; Liu M; Wang J; Sun L; Li Y
    Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of long non-coding RNA LINC00261 is a prognostic marker for patients with non-small cell lung cancer: a preliminary study.
    Liu Y; Xiao N; Xu SF
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5691-5695. PubMed ID: 29272004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
    Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
    Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
    Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
    Zhao T; Wu L; Li X; Dai H; Zhang Z
    Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
    Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
    Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer.
    Fang H; Yang L; Fan Y; Mo C; Luo L; Liang D; Jiang Y
    Medicine (Baltimore); 2020 Dec; 99(50):e21789. PubMed ID: 33327221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
    Zhang E; Li W; Yin D; De W; Zhu L; Sun S; Han L
    Tumour Biol; 2016 Mar; 37(3):4007-15. PubMed ID: 26482621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
    Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
    Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.